Source: IndiaMedToday

Vanta Bioscience Limited: Chennai-based Vanta Bioscience bags order worth Rs 57 lakh

Vanta Bioscience bagged the order from a Singapore-based company to carry out GLP Studies which include bacterial reverse mutation assayChennai-based Vanta Bioscience has received an order of Rs 57 Lakh from a renowned Singapore company to carry out GLP Studies which include bacterial reverse mutation assay, oral toxicity study in vitro tests and other studies.The said studies will be carried out by the company from its state-of-the-art research facility at Gummidipundi, Chennai. The turnaround time of the company for the project will be 26 weeks from receipt of requisite test items and/or such extended period as mutually agreed.The major order has been added to the existing impressive order book of the company comprising multiple studies received by the company which aggregates to over Rs 10 crore.After successfully getting the Resolution proceedings settled, and regaining absolute control of the company, the promoters and directors have refocused their energies to revive the company financially and in all other aspects. With diligent efforts and unwavering support of the Vanta Bioscience family, its employees and all its stakeholders, the company is positive of increasing its market share in the industry thereby increasing the turnover and profits of the company in ...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

CEO

Venkata Rao Sadhanala

CEO Approval Rating

74/100

Read more